Showing results (201-210 of 274) with videos related to
Sort By:
Pageof 28
Pharmacogenetics|August 1, 1996
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanismsE Y Krynetski, H L Tai, C R Yates, et al.Clinical Pharmacology and Therapeutics|July 2, 2010
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivityS-H Chen, D Pei, W Yang, et al.Annals of Internal Medicine|April 15, 1997
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intoleranceC R Yates, E Y Krynetski, T Loennechen, et al.Blood|February 1, 1996
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemiaE Coustan-Smith, A Kitanaka, C H Pui, et al.Seminars in Oncology|February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in childrenJ H Rodman, M V Relling, C F Stewart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.Journal of the National Cancer Institute|December 2, 1999
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locusM V Relling, M L Hancock, G K Rivera, et al.Cancer|April 1, 1982
Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphomaW E Evans, A Tsiatis, G Rivera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemiaM V Relling, H H Mahmoud, C H Pui, et al.The Journal of Pediatrics|October 1, 1994
Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemiaW R Crom, S S de Graaf, T Synold, et al.Pageof 28